About ATNM

Actinium Pharmaceuticals, Inc. is a New York, NY based biopharmaceutical company that develops innovative alpha particle immunotherapeutics based on its proprietary platform for the therapeutic utilization of alpha particle emitting actinium-225 and bismuth-213 radiopharmaceuticals in association with monoclonal antibodies.
Primary Exchange: AMEX
SIC Biological Products, (No Diagnostic Substances)
NAICS Biological Product (except Diagnostic) Manufacturing

ATNM is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
VTI Vanguard Total Stock Market ETF 116.3 B 1.163E+11 3,604 3604 0.0% 0 50 K 50396
VXF Vanguard Extended Market ETF 7.1 B 7.1E+09 3,265 3265 0.0% 0 35 K 35089
ITOT iShares Core S&P Total U.S. Stock Market ETF 21.4 B 2.13666E+10 3,563 3563 0.0% 0 6 K 5854